Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Fireman

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysisAmanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
The New England Journal of Medicine|September 8, 2021
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsMark G Thompson, Edward Stenehjem, Shaun Grannis, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report|July 21, 2022
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022Ruth Link-Gelles, Matthew E Levy, Manjusha Gaglani, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
Pediatrics|April 7, 2023
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and AdolescentsNicola P Klein, Maria Demarco, Katherine E Fleming-Dutra, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysisAmanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
The New England Journal of Medicine|September 8, 2021
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsMark G Thompson, Edward Stenehjem, Shaun Grannis, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report|July 21, 2022
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022Ruth Link-Gelles, Matthew E Levy, Manjusha Gaglani, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
Pediatrics|April 7, 2023
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and AdolescentsNicola P Klein, Maria Demarco, Katherine E Fleming-Dutra, et al.
Pageof 21